GMP prevents excitotoxicity mediated by NMDA receptor activation but not by reversal activity of glutamate transporters in rat hippocampal slices

Brain Research

Volumn 1231, Issue , 2008, Pages 113-120

  Molz, Simone ^a,b   Tharine, Dal Cim ^a   Decker, Helena ^a   Tasca, Carla I ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b UNIVERSIDADE DO CONTESTADO   (Brazil)

Author keywords

Glutamate; Glutamate transporter; Guanosine 5 monophosphate; Hippocampal slice; NMDA

Indexed keywords

DIZOCILPINE; GLUTAMATE TRANSPORTER; GLUTAMIC ACID; GLYCINE; GUANINE NUCLEOTIDE; GUANOSINE PHOSPHATE; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; TRITIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN SLICE; CELL DAMAGE; CELL VIABILITY; CONTROLLED STUDY; DNA FRAGMENTATION; DRUG EFFECT; DRUG MECHANISM; EXCITOTOXICITY; HIPPOCAMPUS; MALE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; WISTAR RAT;

5'-GUANYLIC ACID; ANIMALS; ASPARTIC ACID; BRAIN DISEASES, METABOLIC; CELL SURVIVAL; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; GLUTAMIC ACID; HIPPOCAMPUS; MALE; N-METHYLASPARTATE; NEUROPROTECTIVE AGENTS; NEUROTOXINS; ORGAN CULTURE TECHNIQUES; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE; VESICULAR GLUTAMATE TRANSPORT PROTEINS;

MAMMALIA; RATTUS;

EID: 50649090457     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2008.07.009     Document Type: Article

References (59)

1. Allen N.J., Káradóttir R., and Attwell D. Reversal or reduction of glutamate and GABA transport in CNS pathology and therapy. Pflugers Arch. 449 (2004) 132-142
2. Anderson C.M., and Swanson R.A. Astrocyte glutamate transport: review of properties, regulation, and physiological functions. Glia 32 (2000) 1-14
3. Anderson C.M., Bridges R.J., Chamberlin A.R., Shimamoto K., Yasuda-Kamatani Y., and Swanson R.A. Differing effects of substrate and non-substrate transport inhibitors on glutamate uptake reversal. J. Neurochem. 79 (2001) 1207-1216
4. Ankarcrona M., Dypburkt J.M., Bonfoco E., Zhyvotovsky B., Orrenius S., Lipton S.A., and Nicotera P. Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron 15 (1995) 961-973
5. Baron B.M., Dudley M.W., McCarty D.R., Miller F.P., Reynolds I.J., and Schmidt C.J. Guanine nucleotides are competitive inhibitors of N-methyl-d-aspartate at its receptor site both in vitro and in vivo. J. Pharmacol. Exp. Ther. 250 (1989) 162-169
6. Bonde C., Sarup A., Schousboe A., Gegelashvili G., Zimmer J., and Noraberg J. Neurotoxic and neuroprotective effects of the glutamate transporter inhibitor DL-threo-beta-benzyloxyaspartate (DL-TBOA) during physiological and ischemia-like conditions. Neurochem. Int. 43 (2003) 371-380
7. Bonde C., Noraberg J., Noer H., and Zimmer J. Ionotropic glutamate receptors and glutamate transporters are involved in necrotic neuronal cell death induced by oxygen-glucose deprivation of hippocampal slice cultures. Neuroscience 136 (2005) 779-794
8. Bonfoco E., Krainc D., Ankarcrona M., Nicotera P., and Lipton S.P. Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insult with N-methyl-d-aspartate or nitric oxide in cortical cell cultures. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 7162-7166
9. Burgos J.S., Barat A., and Ramírez G. Guanine nucleotides block agonist-driven 45Ca2 influx in chick embryo retinal explants. NeuroReport 11 (2000) 2303-2305
10. Camacho A., and Massieu L. Role of glutamate transporters in the clearance and release of glutamate during ischemia and its relation to neuronal death. Arch. Med. Res. 37 (2006) 11-18
11. Chen C.J., Liao S.L., and Kuo J.S. Gliotoxic action of glutamate on cultured astrocytes. J. Neurochem. 75 (2000) 1557-1565
12. Chen H.S., and Lipton S.A. The chemical biology of clinically tolerated NMDA receptor antagonists. J. Neurochem. 97 (2006) 1611-1626
13. Choi D.W. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1 (1988) 623-634
14. Choi D.W. Excitotoxic cell death. J. Neurobiol. 23 (1992) 1261-1276
15. Ciccarelli R., Di Iorio P., Giuliani P., D'Alimonte I., Ballerini P., Caciagli F., and Rathbone M.P. Rat cultured astrocytes release guanine-based purines in basal conditions and after hypoxia/hypoglycemia. Glia 25 (1999) 93-98
16. Ciccarelli R., Ballerini P., Sabatino G., Rathbone M.P., D'Onofrio M., Caciagli F., and Di Iorio P. Involvement of astrocytes in purine-mediated reparative processes in the brain. Int. J. Dev. Neurosci. 19 (2001) 395-414
17. Danbolt N.C. Glutamate uptake. Prog. Neurobiol. 65 (2001) 1-105
18. Decker H., Francisco S.S., Mendes-de-Aguiar C.B., Romão L.F., Boeck C.R., Trentin A.G., Moura-Neto V., and Tasca C.I. Guanine derivatives modulate extracellular matrix proteins organization and improve neuron-astrocyte co-culture. J. Neurosci. Res. 85 (2007) 1943-1951
19. Dev K.K., Roberts P.J., and Henley J.M. Characterisation of the interaction between guanyl nucleotides and AMPA receptors in rat brain. Neuropharmacology 35 (1996) 1583-1593
20. Frizzo M.E., Lara D.R., Dahm K.C., Prokopiuk A.S., Swanson R.A., and Souza D.O. Activation of glutamate uptake by guanosine in primary astrocyte cultures. NeuroReport 12 (2001) 879-881
21. Frizzo M.E., Antunes Soares F.A., Dall'Onder L.P., Lara D.R., Swanson R.A., and Souza D.O. Extracellular conversion of guanine-based purines to guanosine specifically enhances astrocyte glutamate uptake. Brain Res. 972 (2003) 84-89
22. Ikonomidou C., and Turski L. Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury?. Lancet Neurol. 1 (2002) 383-386
23. Lipton S.A. Paradigm shift in NMDA receptor antagonist drug development: molecular mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer's disease and other neurologic disorders. J. Alzheimer. Dis. 6 6 Suppl (2004) S61-S74
24. Lowry O.H., Rosembrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
25. Madl J.E., and Buegesser K. Adenosine triphosphate depletion reverses sodium-dependent, neuronal uptake of glutamate in rat hippocampal slices. J. Neurosci. 13 (1993) 4429-4444
26. Malcon C., Achaval M., Komlos F., Partata W., Sauressing M., Ramírez G., and Souza D.O. GMP protects against quinolinic acid-induced loss of NADPH-diaphorase-positive cells in the rat striatum. Neurosci. Lett. 225 (1997) 145-148
27. Maragakis N.J., and Rothstein J.D. Glutamate transporters: animal models to neurologic disease. Neurobiol. Dis. 15 (2004) 461-473
28. Mattson M.P. Apoptosis in neurodegenerative disorders. Nat. Rev. Mol. Cell Biol. 1 (2000) 120-129
29. Mattson M.P. Excitotoxic and excitoprotective mechanisms: abundant targets for the prevention and treatment of neurodegenerative disorders. Neuromol. Med. 3 (2003) 65-94
30. Matute C., Alberdi E., Ibarretxe G., and Sánchez-Gómez M.V. Excitotoxicity in glial cells. Eur. J. Pharmacol. 447 (2002) 239-246
31. Meldrum B.S. Glutamate as a neurotransmitter in the brain: review of physiology and pathology. J. Nutr. 130 (2000) 1007S-1015S
32. Mendieta J., Gago F., and Ramírez G. Binding of 5′-GMP to the GluR2 AMPA receptor: insight from targeted molecular dynamics simulations. Biochemistry 44 (2005) 14470-14476
33. Molz S., Oliveira I.J.L., Decker H., Souza D.O., and Tasca C.I. Neurotoxicity induced by glutamate in glucose-deprived rat hippocampal slices is prevented by GMP. Neurochem. Res. 30 (2005) 83-89
34. MAPK signaling. Neurochem. Res. 33 (2008) 27-36
35. Morciano M., Ortinau S., and Zimmermann H. Guanine nucleotides inhibit NMDA and kainate-induced neurotoxicity in cultured rat hippocampal and neocortical neurons. Neurochem. Int. 45 (2004) 95-101
36. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity. J. Immunol. Methods 65 (1983) 55-63
37. Muir K.W. Glutamate-based therapeutic approaches: clinical trials with NMDA antagonists. Curr. Opin. Pharmacol. 6 (2006) 53-60
38. Neary J.T., Rathbone M.P., Cattabeni F., Abbracchio M.P., and Burnstock G. Trophic actions of extracellular nucleotides and nucleosides on glial and neuronal cells. Trends Neurosci. 19 (1996) 13-18
39. Oleskovicz S.P., Martins M.C., Leal R.B., and Tasca C.I. Mechanism of guanosine-induced neuroprotection in rat hippocampal slices submitted to oxygen-glucose deprivation. Neurochem. Int. 52 (2008) 411-418
40. Oliveira I.J.L., Molz S., Souza D.O., and Tasca C.I. Neuroprotective effect of GMP in hippocampal slices submitted to an in vitro model of ischemia. Cell. Mol. Neurobiol. 22 (2002) 335-344
41. Park C.K., Nehls D.G., Graham D.I., Teasdale G.M., and McCulloch J. The glutamate antagonist MK-801 reduces focal ischemic brain damage in the rat. Ann. Neurol. 24 (1988) 543-551
42. 3H]AMPA binding at postsynaptic densities from cerebral cortex of rats. Brain Res. 928 (2002) 106-112
43. Re D.B., Nafia I., Melon C., Shimamoto K., Kerkerian-Le Goff L., and Had-Aissouni L. Glutamate leakage from a compartmentalized intracellular metabolic pool and activation of the lipoxygenase pathway mediate oxidative astrocyte death by reversed glutamate transport. Glia 54 (2006) 47-57
44. Re D.B., Boucraut J., Samuel D., Birman S., Kerkerian-Le Goff L., and Had-Aissouni L. Glutamate transport alteration triggers differentiation-state selective oxidative death of cultured astrocytes: a mechanism different from excitotoxicity depending on intracellular GSH contents. J. Neurochem. 85 (2003) 1159-1170
45. Regner A., Ramirez G., Belló-Klein D., and Souza D. Effects of guanine nucleotides on glutamate-induced chemiluminescence in rat hippocampal slices submitted to hypoxia. Neurochem. Res. 23 (1998) 519-524
46. Rossi D.J., Oshima T., and Attwell D. Glutamate release in severe brain ischaemia is mainly by reversed uptake. Nature 403 (2000) 316-321
47. Santos T.G., Souza D.O., and Tasca C.I. GTP uptake into rat brain synaptic vesicles. Brain Res. 1070 (2006) 71-76
48. Sattler R., and Rothstein J.D. Regulation and dysregulation of glutamate transporters. Handb. Exp. Pharmacol. 175 (2006) 277-303
49. Segovia G., Porras A., Del Arco A., and Mora F. Glutamatergic neurotransmission in aging: a critical perspective. Mech. Ageing Dev. 122 (2001) 1-29
50. Schmidt A.P., Lara D.R., de Faria Maraschin J., da Silveira Perla A., and Onofre Souza D. Guanosine and GMP prevent seizures induced by quinolinic acid in mice. Brain Res. 864 (2000) 40-43
51. Schmidt A.P., Lara D.R., and Souza D.O. Proposal of a guanine-based purinergic system in the mammalian central nervous system. Pharmacol. Ther. 116 (2007) 401-416
52. Souza D.O., and Ramírez G. Effects of guanine nucleotides on kainic acid binding and on adenylate cyclase in chick optic tectum and cerebellum. J. Mol. Neurosci. 3 (1991) 39-45
53. Stone T.W., and Addae J.I. The pharmacological manipulation of glutamate receptors and neuroprotection. Eur. J. Pharmacol. 447 (2002) 285-296
54. Tasca C.I., Wolfchuk S., Souza D.O., Ramirez G., and Rodnight R. Guanine nucleotides inhibit the stimulation of GFAP phosphorylation by glutamate. NeuroReport 6 (1995) 249-252
55. Tasca C.I., Cardoso L.F., Martini L.H., Ramírez G., and Souza D.O. Guanine nucleotides inhibit cAMP accumulation induced by metabotropic glutamate receptor activation. Neurochem. Res. 23 (1998) 183-188
56. Tasca C.I., Santos T.G., Tavares R.G., Battastini A.M., Rocha J.B., and Souza D.O. Guanine derivatives modulate l-glutamate uptake into rat brain synaptic vesicles. Neurochem. Int. 44 (2004) 423-431
57. Tavares R.G., Tasca C.I., Santos C.E., Alves L.B., Porciúncula L.O., Emanuelli T., and Souza D.O. Quinolinic acid stimulates synaptosomal glutamate release and inhibits glutamate uptake into astrocytes. Neurochem. Int. 40 (2002) 621-627
58. Yang G.-M., and Paul S.M. Cultured cerebellar granule neurons as a model of neuronal apoptosis. In: Poirier J. (Ed). Neuromethods vol. 29 (1997), Humana Press Inc. 47-66
59. Zimmermann H. Biochemistry, localization and functional roles of ecto-nucleotidases in the nervous system. Prog. Neurobiol. 49 (1996) 589-618